Amplicon details |
||
Amplicon: |
195 bp | |
1 gctcctacaa atgccatcat tgcgataaag gaaaggccat cgttgaagat 51 gcctctgccg acagtggtcc caaagatgga cccccaccca cgaggagcat 101 cgtggaaaaa gaagacgttc caaccacgtc ttcaaagcaa gtggattgat 151 gtgatatctc cactgacgta agggatgacg cacaatccca ctatc |
||
| Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
|---|---|---|---|---|---|---|---|
| HW671992.1 | emblrelpat | JP 2013545454-A/15: Plant Expressio... | 5800 bp | synthetic construct | QL-ELE-00-001 | 195 bp | View |
| GZ642959.1 | emblrelpat | Sequence 66 from patent US 8338152. | 18661 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
| AX765962.1 | emblrelpat | Sequence 48 from Patent WO02097097. | 5511 bp | synthetic construct | QL-ELE-00-001 | 195 bp | View |
| GZ800415.1 | emblrelpat | Sequence 7 from patent US 8404926. | 9060 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
| BD251965.1 | emblrelpat | JP 2002531097-A/27: Artificial matr... | 9361 bp | synthetic construct | QL-ELE-00-001 | 195 bp | View |
| GZ800419.1 | emblrelpat | Sequence 11 from patent US 8404926. | 9142 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
| GZ800443.1 | emblrelpat | Sequence 35 from patent US 8404926. | 19472 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
| BD251966.1 | emblrelpat | JP 2002531097-A/28: Artificial matr... | 10629 bp | synthetic construct | QL-ELE-00-001 | 195 bp | View |
| BD394364.1 | emblrelpat | A construct capable of release in c... | 1294 bp | synthetic construct | QL-ELE-00-001 | 195 bp | View |
| GZ821262.1 | emblrelpat | Sequence 100 from patent US 8420892. | 15114 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
| HW671993.1 | emblrelpat | JP 2013545454-A/16: Plant Expressio... | 5740 bp | synthetic construct | QL-ELE-00-001 | 195 bp | View |
| GZ821263.1 | emblrelpat | Sequence 101 from patent US 8420892. | 13268 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
| BD394366.1 | emblrelpat | A construct capable of release in c... | 1512 bp | synthetic construct | QL-ELE-00-001 | 195 bp | View |
| GZ845215.1 | emblrelpat | Sequence 170 from patent US 8389808. | 21767 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
| HC476825.1 | emblrelpat | Sequence 1 from Patent EP2166103. | 12287 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
| CQ792265.1 | emblrelpat | Sequence 10 from Patent WO2004020642. | 5250 bp | synthetic construct | QL-ELE-00-001 | 195 bp | View |
| HC476826.1 | emblrelpat | Sequence 2 from Patent EP2166103. | 12261 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
| CQ792311.1 | emblrelpat | Sequence 56 from Patent WO2004020642. | 6299 bp | synthetic construct | QL-ELE-00-001 | 195 bp | View |
| KJ608130.1 | emblreltgn | Glycine max transgenic line A5547-1... | 530 bp | Glycine max | QL-ELE-00-001 | 195 bp | View |
| MV836401.1 | emblrelpat | Sequence 32 from patent US 10822612. | 12286 bp | unidentified | QL-ELE-00-001 | 195 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.